vimarsana.com
Home
Live Updates
MaxCyte, Inc. Signs Strategic Platform License Agreement with Legend Biotech to Accelerate Cell Therapy Discovery and Development : vimarsana.com
MaxCyte, Inc. Signs Strategic Platform License Agreement with Legend Biotech to Accelerate Cell Therapy Discovery and Development
MaxCyte, Inc. announced it has entered into a strategic platform license agreement with Legend Biotech. Under the terms of the SPL, Legend Biotech obtains a non-exclusive worldwide license to use...
Related Keywords
,
Maxcyte Inc ,
Legend Biotech ,
Flow Electroporation ,
Licensed Products ,
vimarsana.com © 2020. All Rights Reserved.